Document:

EX-4.4

 Exhibit 4.4 

Execution Version 

This FIFTEENTH SUPPLEMENTAL INDENTURE (this “Fifteenth Supplemental Indenture”), dated as of June 11, 2021, among
SEASPAN CORPORATION, a corporation duly organized and existing under the laws of the Republic of the Marshall Islands with limited liability (the “Company”), and THE BANK OF NEW YORK MELLON, as trustee (the
“Trustee”). 
 RECITALS 

WHEREAS, the Company and the Trustee have heretofore executed and delivered an indenture, dated as of October 10, 2017 (the “Base
Indenture”), providing for the issuance by the Company from time to time of its Securities to be issued in one or more series, which Base Indenture was amended and supplemented by (i) a second supplemental indenture, dated as of
February 14, 2018 (the “Second Supplemental Indenture”), among the Company, the guarantors party thereto and the Trustee, providing for the issuance of a series of Securities designated as its “5.50% Senior Notes due
2025”, in an aggregate principal amount of $250,000,000 (the “2025 Notes”), (ii) a third supplemental indenture, dated as of February 22, 2018 (the “Third Supplemental Indenture”), among the Company, the
guarantors party thereto and the Trustee, (iii) a fourth supplemental indenture, dated as of March 22, 2018 (the “Fourth Supplemental Indenture”), among the Company, the guarantors party thereto and the Trustee,
(iv) a fifth supplemental indenture, dated as of March 26, 2018 (the “Fifth Supplemental Indenture”), among the Company, the guarantors party thereto and the Trustee, (v) a sixth supplemental indenture, dated as of
March 26, 2018 (the “Sixth Supplemental Indenture”), among the Company, the guarantors party thereto and the Trustee, (vi) a seventh supplemental indenture, dated as of June 8, 2018 (the “Seventh Supplemental
Indenture”), among the Company, the guarantors party thereto and the Trustee, (vii) an eighth supplemental indenture, dated as of July 16, 2018 (the “Eighth Supplemental Indenture”), among the Company, the
guarantors party thereto and the Trustee, (viii) a ninth supplemental indenture, dated as of January 15, 2019 (the “Ninth Supplemental Indenture”), among the Company, the guarantors party thereto and the Trustee, providing
for the issuance of a series of Securities designated as its “5.50% Senior Notes due 2026”, in an aggregate principal amount of $250,000,000 (the “2026 Notes”), (ix) a tenth supplemental indenture, dated as of
January 15, 2019 (the “Tenth Supplemental Indenture”), among the Company, the guarantors party thereto and the Trustee, (x) an eleventh supplemental indenture, dated as of August 22, 2019 (the “Eleventh
Supplemental Indenture”), among the Company, the guarantors party thereto and the Trustee, (xi) a twelfth supplemental indenture, dated as of August 22, 2019 (the “Twelfth Supplemental Indenture”), among the
Company, the guarantors party thereto and the Trustee, (xii) a thirteenth supplemental indenture, dated as of January 13, 2020, among the Company, the guarantors party thereto and the Trustee (the “Thirteenth Supplemental
Indenture”) and (xiii) a fourteenth supplemental indenture, dated as of February 28, 2020 (the “Fourteenth Supplemental Indenture”), among the Company, Atlas Corp., a corporation duly organized and existing under
the laws of the Republic of the Marshall Islands with limited liability, the subsidiary guarantors party thereto, and the Trustee, providing for the issuance of a series of Securities designated as its “5.50% Senior Notes due 2027”, in an
aggregate principal amount of $100,000,000 (the “2027 Notes” and, together with the 2025 Notes and the 2026 Notes, the “Notes”) ((1) the Base Indenture, the Second Supplemental Indenture, the Third Supplemental
Indenture, the Fourth Supplemental Indenture, the Fifth Supplemental Indenture, the Sixth Supplemental Indenture, the Seventh Supplemental Indenture, the Eighth Supplemental Indenture, the Tenth Supplemental Indenture, the Eleventh Supplemental
Indenture and the Thirteenth Supplemental Indenture, the “2025 Notes Indenture”; (2) the Base Indenture, the Ninth Supplemental Indenture, the Twelfth Supplemental Indenture and the Thirteenth Supplemental Indenture, the
“2026 Notes Indenture”; and (3) the Base Indenture and the Fourteenth Supplemental Indenture, the “2027 Notes Indenture”)); 

WHEREAS, Section 7.02 of the 2025 Notes Indenture provides that no supplemental indenture, without the consent of each Holder of
Outstanding 2025 Notes, shall effect certain matters, including changing the redemption provisions, releasing any Guarantor from any of its obligations under its Guarantee or the Indenture and modifying the provisions relating to the Annual Put
Right; 
 WHEREAS, Section 7.02 of the 2025 Notes Indenture further provides that the Company and the Trustee may, with the consent of
the Holders of not less than a majority in principal amount of the Outstanding 2025 Notes, enter into indentures supplemental to the 2025 Notes Indenture for the purpose of adding any provisions to or changing in any manner or eliminating any of the
provisions of the 2025 Notes Indenture or of modifying in any manner the rights of the Holders of the 2025 Notes, subject to certain exceptions noted therein; 

 WHEREAS, (i) Section 11.02 of the 2025 Notes Indenture provides that the Company
may amend, supplement or waive the A&R Pledge and Collateral Agent Agreement (as defined in the 2025 Notes Indenture) or the provisions of the 2025 Notes Indenture dealing with the Collateral (as defined in the 2025 Notes Indenture) or the
A&R Pledge and Collateral Agent Agreement with the consent of each Holder of 2025 Notes and (ii) Section 11.07 of the 2025 Notes Indenture authorizes the Trustee to release any lien on the Collateral and/or to terminate the A&R
Pledge and Collateral Agent Agreement if consented to by the holders of each Outstanding 2025 Note; 
 WHEREAS, Section 7.02 of the
2026 Notes Indenture provides that no supplemental indenture, without the consent of each Holder of Outstanding 2026 Notes, shall effect certain matters, including changing the redemption provisions, releasing any Guarantor from any of its
obligations under its Guarantee or the Indenture and modifying the provisions relating to the Annual Put Right; 
 WHEREAS,
Section 7.02 of the 2026 Notes Indenture further provides that the Company and the Trustee may, with the consent of the Holders of not less than a majority in principal amount of the Outstanding 2026 Notes, enter into indentures supplemental to
the 2026 Notes Indenture for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of the 2026 Notes Indenture or of modifying in any manner the rights of the Holders of the 2026 Notes, subject to
certain exceptions noted therein; 
 WHEREAS, (i) Section 11.02 of the 2026 Notes Indenture provides that the Company may amend,
supplement or waive the A&R Pledge and Collateral Agent Agreement (as defined in the 2026 Notes Indenture) or the provisions of the 2026 Notes Indenture dealing with the Collateral (as defined in the 2026 Notes Indenture) or the A&R Pledge
and Collateral Agent Agreement with the consent of each Holder of 2026 Notes and (ii) Section 11.07 of the 2026 Notes Indenture authorizes the Trustee to release any lien on the Collateral and/or to terminate the A&R Pledge and
Collateral Agent Agreement if consented to by the holders of each Outstanding 2026 Note; 
 WHEREAS, Section 7.02 of the 2027 Notes
Indenture provides that no supplemental indenture, without the consent of each Holder of Outstanding 2027 Notes, shall effect certain matters, including changing the redemption provisions, releasing any Guarantor from any of its obligations under
its Guarantee or the Indenture and modifying the provisions relating to the Annual Put Right; 
 WHEREAS, Section 7.02 of the 2027
Notes Indenture further provides that the Company and the Trustee may, with the consent of the Holders of not less than a majority in principal amount of the Outstanding 2027 Notes, enter into indentures supplemental to the 2027 Notes Indenture for
the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of the 2027 Notes Indenture or of modifying in any manner the rights of the Holders of the 2027 Notes, subject to certain exceptions noted
therein; 
 WHEREAS, (i) Section 11.02 of the 2027 Notes Indenture provides that the Company may amend, supplement or waive the
A&R Pledge and Collateral Agent Agreement (as defined in the 2027 Notes Indenture) or the provisions of the 2026 Notes Indenture dealing with the Collateral (as defined in the 2027 Notes Indenture) or the A&R Pledge and Collateral Agent
Agreement with the consent of each Holder of 2027 Notes and (ii) Section 11.07 of the 2027 Notes Indenture authorizes the Trustee to release any lien on the Collateral and/or to terminate the A&R Pledge and Collateral Agent Agreement
if consented to by the holders of each Outstanding 2027 Note; 
 WHEREAS, in accordance with Section 1.4 of the Base Indenture,
Section 7.02 of the 2025 Notes Indenture, Section 7.02 of the 2026 Notes Indenture and Section 7.02 of the 2027 Notes Indenture, each of the Holders of the Notes have duly authorized the execution and delivery of this Fifteenth
Supplemental Indenture; 
 WHEREAS, the Company intends by this Fifteenth Supplemental Indenture to evidence the amendment of certain
provisions under the 2025 Notes Indenture, the 2026 Notes Indenture and the 2027 Notes Indenture; 

 WHEREAS, pursuant to Section 7.02 of the 2025 Notes Indenture, Section 7.02 of the
2026 Notes Indenture and Section 7.02 of the 2027 Notes Indenture, the Trustee and the Company have received the required consents of the Holders of each of the 2025 Notes, the 2026 Notes and the 2027 Notes and are authorized to execute and
deliver this Fifteenth Supplemental Indenture to amend or supplement the 2025 Notes Indenture, the 2026 Notes Indenture and the 2027 Notes Indenture as set forth herein; and 

WHEREAS, all actions required to be taken by the Company under the 2025 Notes Indenture, the 2026 Notes Indenture and the 2027 Notes Indenture
to make this Fifteenth Supplemental Indenture a valid, binding and legal agreement of the Company have been done. 
 NOW, THEREFORE, in
consideration of the premises and for other good and valuable consideration, the sufficiency and adequacy of which are hereby acknowledged, the parties hereto hereby agree as follows: 

ARTICLE I 
 DEFINITIONS
AND INCORPORATION BY REFERENCE 
 Section 1.01 Definitions. All capitalized terms used and not otherwise defined herein
shall have the meanings ascribed thereto in the 2025 Notes Indenture, the 2026 Notes Indenture or the 2027 Notes Indenture, as applicable. 

ARTICLE II 
 AMENDMENTS

 Section 2.01 Deletions and Amendments to Definitions. 

(a) The definitions of “Collateral”, “GCI”, “LLC Interests” and “Seaspan Investment”
contained in each of the Sixth Supplemental Indenture in connection with the 2025 Notes, the Ninth Supplemental Indenture in connection with the 2026 Notes and the Fourteenth Supplemental Indenture in connection with the 2027 Notes are hereby
deleted in their entirety. 
 (b) Clause (a) of the definition of “Permitted Security” in each of the Seventh
Supplemental Indenture in connection with the 2025 Notes, the Ninth Supplemental Indenture in connection with the 2026 Notes and the Fourteenth Supplemental Indenture in connection with the 2027 Notes is hereby deleted in its entirety. 

Section 2.02 Amendment of Redemption Provisions. Section 3.02 Optional Redemption in each of the Second
Supplemental Indenture in connection with the 2025 Notes, the Ninth Supplemental Indenture in connection with the 2026 Notes and the Fourteenth Supplemental Indenture in connection with the 2027 Notes is hereby deleted in its entirety and replaced
in lieu thereof with the following: 
 “Section 3.02 Optional Redemption. The Company may redeem the Notes at its option,
in whole or in part, at any time, upon not less than 30 nor more than 60 days’ prior notice, at a Redemption Price equal to 100% of their principal amount, plus accrued and unpaid interest (if any) and Additional Interest (if any) to, but not
including, the Redemption Date. Article 11 of the Base Indenture shall apply to any such redemption of the Notes.” 
 Section 2.03
Deletion of Annual Put Right. Section 4.02 Annual Put Right in each of the Eighth Supplemental Indenture in connection with the 2025 Notes, the Ninth Supplemental Indenture in connection with the 2026 Notes and the
Fourteenth Supplemental Indenture in connection with the 2027 Notes are each hereby deleted in their entirety. 

 Section 2.04 Amendment of Certain Covenants. Section 5.08
Subsidiary Guarantee in the Second Supplemental Indenture in connection with the 2025 Notes, Section 3.03 India Guarantee Regulatory Approval in the Seventh Supplemental Indenture in connection with the 2025 Notes,
Section 5.08 Subsidiary Guarantee and Section 9.08 India Guarantee Regulatory Approval in the Ninth Supplemental Indenture in connection with the 2026 Notes and
Section 5.08 Subsidiary Guarantee and Section 9.08 India Guarantee Regulatory Approval in the Fourteenth Supplemental Indenture in connection with the 2027 Notes are each hereby deleted in their
entirety. 
 Section 2.05 Events of Default. Clauses (c) and (d) of Section 6.02 Additional Events of
Default the Second Supplemental Indenture in connection with the 2025 Notes, clauses (c), (d) and (e) of Section 6.02 Additional Events of Default in the Ninth Supplemental Indenture in connection with the 2026
Notes, and clauses (c), (d) and (e) of Section 6.02 Additional Events of Default in the Fourteenth Supplemental Indenture in connection with the 2027 Notes are each hereby deleted in their entirety. 

Section 2.06 Supplemental Indentures with Consent of Holders. Clauses (6) and (7) of Section 7.02
Supplemental Indentures with Consent of Holders in the Second Supplemental Indenture in connection with the 2025 Notes, and Clauses 6. and 7. of Section 7.02 Supplemental Indentures with Consent of Holders in the Ninth
Supplemental Indenture in connection with the 2026 Notes and Clauses 6. and 7. of Section 7.02 Supplemental Indentures with Consent of Holders in the Fourteenth Supplemental Indenture in connection with the 2027 Notes, are
each hereby deleted in their entirety. 
 Section 2.07 Guarantees. Article IX Guarantees in each of the Second
Supplemental Indenture in connection with the 2025 Notes, the Ninth Supplemental Indenture in connection with the 2026 Notes and the Fourteenth Supplemental Indenture in connection with the 2027 Notes is hereby deleted in its entirety. 

Section 2.08 Amendment of the 2025 Notes, 2026 Notes and 2027 Notes. Each Outstanding 2025 Note, 2026 Note and 2027 Note is hereby
amended by: 
 (a) amending the parenthetical in the first sentence of the second paragraph of such Notes to read in its
entirety as follows: 
 “(including, without limitation, any purchase price relating to a Change of Control)”; 

(b) deleting the references to “the Guarantors” in the third, tenth and sixteenth paragraphs; 

(c) deleting the ninth paragraph in its entirety; and 

(d) amending the form of “OPTION OF HOLDER TO ELECT PURCHASE” attached to such note to remove the references to elect
to purchase pursuant to Section 4.02. 
 ARTICLE III 

RELEASE OF GUARANTORS 

Section 3.01 Termination and Release. 

(a) The Trustee hereby acknowledges and agrees that each Guarantor under the 2025 Notes Indenture is hereby released and
discharged from its Guarantee under the 2025 Notes, and each Guarantor is released from all its obligations under the 2025 Notes Indenture as it relates to the 2025 Notes. 

 (b) The Trustee hereby acknowledges and agrees that each Guarantor under the
2026 Notes Indenture is hereby released and discharged from its Guarantee under the 2026 Notes, and each Guarantor is released from all its obligations under the 2026 Notes Indenture as it relates to the 2026 Notes. 

(c) The Trustee hereby acknowledges and agrees that each Guarantor under the 2027 Notes Indenture is hereby released and
discharged from its Guarantee under the 2027 Notes, and each Guarantor is released from all its obligations under the 2027 Notes Indenture as it relates to the 2027 Notes. 

Section 3.02 Further Assurances. The Trustee hereby agrees to deliver to the Company, at the Company’s sole cost and expense,
including reasonable legal fees and out-of-pocket expenses, such releases, discharges and similar documents as the Company may reasonably request in connection with the
releases described in Section 3.01 above. 
 ARTICLE IV 

RELEASE OF COLLATERAL 

Section 4.01 Termination and Release. 

(a) The Trustee hereby acknowledges and agrees that (i) all liens on the Collateral or any other assets securing the
Company’s obligations under the 2025 Notes Indenture with respect to the 2025 Notes are hereby released, (ii) all liens on the Collateral or any other assets securing the Company’s obligations under the 2026 Notes Indenture with
respect to the 2026 Notes are hereby released and (iii) all liens on the Collateral or any other assets securing the Company’s obligations under the 2027 Notes Indenture with respect to the 2027 Notes are hereby released. 

(b) The Trustee hereby acknowledges and agrees that the A&R Pledge and Collateral Agent Agreement is hereby terminated
concurrently with the execution of this Fifteenth Supplemental Indenture; provided however that any provisions which survive termination by their express terms shall continue for the benefit of the Trustee and Collateral Agent. 

Section 4.02 Termination of Articles III, IV, V and VI. 

(a) Article III Collateral in the Sixth Supplemental Indenture in connection with the 2025 Notes is hereby deleted in
its entirety. 
 (b) Article IV Events of Default in the Sixth Supplemental Indenture in connection with the 2025
Notes is hereby deleted in its entirety. 
 (c) Article V Amendment to the Seaspan Investment Pledge Agreement in the
Sixth Supplemental Indenture in connection with the 2025 Notes is hereby deleted in its entirety. 
 (d) Article VI
Seaspan Investment Pledge Agreement and Collateral in the Sixth Supplemental Indenture in connection with the 2025 Notes is hereby deleted in its entirety. 

Section 4.03 Termination of Article XI. Article XI A&R Pledge and Collateral Agent Agreement and Collateral in the
Ninth Supplemental Indenture in connection with the 2026 Notes and Article XI A&R Pledge and Collateral Agent Agreement and Collateral in the Fourteenth Supplemental Indenture in connection with the 2027 Notes are each hereby deleted in
their entirety. 
 Section 4.04 Further Assurances. The Trustee hereby agrees to deliver to the Company, at the Company’s
sole cost and expense, including reasonable legal fees and out-of-pocket expenses, such releases, discharges and similar documents as the Company may reasonably request
in connection with the releases described in Section 4.01 above. 

 ARTICLE V 

MISCELLANEOUS 

Section 5.01 Ratification of 2025 Notes Indenture. This Fifteenth Supplemental Indenture is executed and shall be constructed as
an indenture supplement to the Base Indenture, as amended and supplemented by the Second Supplemental Indenture, the Third Supplemental Indenture, the Fourth Supplemental Indenture, the Fifth Supplemental Indenture, the Sixth Supplemental Indenture,
the Seventh Supplemental Indenture, the Eighth Supplemental Indenture, the Tenth Supplemental Indenture, the Eleventh Supplemental Indenture and the Thirteenth Supplemental Indenture and as further supplemented and modified hereby in respect of the
2025 Notes, the Base Indenture, the Second Supplemental Indenture, the Third Supplemental Indenture, the Fourth Supplemental Indenture, the Fifth Supplemental Indenture, the Sixth Supplemental Indenture, the Seventh Supplemental Indenture, the
Eighth Supplemental Indenture, the Tenth Supplemental Indenture, the Eleventh Supplemental Indenture and the Thirteenth Supplemental Indenture in respect of the 2025 Notes are in all respects ratified and confirmed, and the Base Indenture, the
Second Supplemental Indenture, the Third Supplemental Indenture, the Fourth Supplemental Indenture, the Fifth Supplemental Indenture, the Sixth Supplemental Indenture, the Seventh Supplemental Indenture, the Eighth Supplemental Indenture, the Tenth
Supplemental Indenture, the Eleventh Supplemental Indenture and the Thirteenth Supplemental Indenture in respect of the 2025 Notes shall be read, taken and constructed as one and the same instrument. 

Section 5.02 Ratification of 2026 Notes Indenture. This Fifteenth Supplemental Indenture is executed and shall be constructed as
an indenture supplement to the Base Indenture, as amended and supplemented by the Ninth Supplemental Indenture, the Twelfth Supplemental Indenture and the Thirteenth Supplemental Indenture with respect to the 2026 Notes and as further supplemented
and modified hereby, the Base Indenture, the Ninth Supplemental Indenture, the Twelfth Supplemental Indenture and the Thirteenth Supplemental Indenture with respect to the 2026 Notes are in all respects ratified and confirmed, and the Base
Indenture, the Ninth Supplemental Indenture, the Twelfth Supplemental Indenture and the Thirteenth Supplemental Indenture with respect to the 2026 Notes shall be read, taken and constructed as one and the same instrument. 

Section 5.03 Ratification of 2027 Notes Indenture. This Fifteenth Supplemental Indenture is executed and shall be constructed as
an indenture supplement to the Base Indenture, as amended and supplemented by the Fourteenth Supplemental Indenture with respect to the 2027 Notes and as further supplemented and modified hereby, the Base Indenture and the Fourteenth Supplemental
Indenture with respect to the 2027 Notes are in all respects ratified and confirmed, and the Base Indenture and the Fourteenth Supplemental Indenture with respect to the 2027 Notes shall be read, taken and constructed as one and the same instrument.

 Section 5.04 Trust Indenture Act Controls. If any provision of this Fifteenth Supplemental Indenture limits, qualifies or
conflicts with another provision that is required or deemed to be included in this Fifteenth Supplemental Indenture by the Trust Indenture Act, the required or deemed provision shall control. 

Section 5.05 Notices. All notices and other communications shall be given as provided in the 2025 Notes Indenture, the 2026 Notes
Indenture or the 2027 Notes Indenture, as applicable. 
 Section 5.06 Governing Law. THIS FIFTEENTH SUPPLEMENTAL INDENTURE SHALL
BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO AGREEMENTS MADE OR INSTRUMENTS ENTERED INTO AND, IN EACH CASE, PERFORMED IN THE STATE OF NEW YORK. Any dispute, action or proceeding arising out of or
relating to this Fifteenth Supplemental Indenture in respect hereof or the rights of any party under this Fifteenth Supplemental Indenture shall be exclusively maintained in the U.S. federal or New York State Court sitting in the Borough of

 
Manhattan, The City of New York, New York. Each of the parties hereto: (i) agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other
jurisdictions by suit on the judgment or in any other manner provided by law, and (ii) irrevocably submits to the jurisdiction of such courts in any suit, action or proceeding. Each party to this Fifteenth Supplemental Indenture irrevocably
waives, to the fullest extent permitted by applicable law, all right of trial by jury in any action, proceeding or counterclaim based on, or arising out of, under or in connection with this Fifteenth Supplemental Indenture or any matter arising
hereunder. 
 Section 5.07 Successors. All covenants and agreements in this Fifteenth Supplemental Indenture by the Company
shall bind its successors and assigns, whether so expressed or not. 
 Section 5.08 Counterparts. This Fifteenth Supplemental
Indenture may be executed in several counterparts, each of which shall be an original and all of which shall constitute but one and the same instrument. Counterparts may be executed either in original, facsimile or electronic (i.e., “pdf”
or “tif”) form and the parties hereto adopt any signatures received by facsimile or electronic (i.e., “pdf” or “tif”) transmission as the original signature of such party. 

Section 5.09 Headings. The Article and Section headings of this Fifteenth Supplemental Indenture are for convenience only and
shall not affect the construction hereof. 
 Section 5.10 Trustee Not Responsible for Recitals. The recitals contained herein
shall be taken as the statements of the Company and the Guarantors and the Trustee assumes no responsibility for their correctness. The Trustee makes no representations as to the validity or sufficiency of this Fifteenth Supplemental Indenture,
except that the Trustee represents that it is duly authorized under its corporate bylaws to execute and deliver this Fifteenth Supplemental Indenture and perform its obligations hereunder. 

Section 5.11 Notices, etc. Each Holder of the 2026 Notes and the 2027 Notes hereby waives any notice, consent, requirement or
condition contained in the 2026 Notes Indenture or the 2027 Notes Indenture, as applicable, in connection with the transfer of any 2026 Notes or 2027 Notes from any Holder to the Company or any Affiliate of the Company. 

[SIGNATURE PAGES TO FOLLOW] 

 IN WITNESS WHEREOF, the parties have caused this Fifteenth Supplemental Indenture to be duly
executed as of the date first written above. 
  

			
	COMPANY:
	
	SEASPAN CORPORATION
		
	By:	 	 /s/ Graham Talbot

		 	Name: Graham Talbot
		 	Title: Chief Financial Officer

 [Signature page to Fifteenth Supplemental Indenture] 

 
			
	
	TRUSTEE:
	
	THE BANK OF NEW YORK MELLON, as Trustee
		
	By:	 	 /s/ Teresa H. Wyszomierski

		 	Name: Teresa H. Wyszomierski
		 	Title: Vice President

 [Signature page to Fifteenth Supplemental Indenture]Exhibit 10.1

 

BEAM GLOBAL

2021 EQUITY INCENTIVE PLAN

 

1.             PURPOSE.  The purpose of this Plan is to provide incentives to attract, retain and motivate eligible persons whose
present and potential contributions are important to the success of the Company, and any Parents, Subsidiaries and Affiliates that exist
now or in the future, by offering them an opportunity to participate in the Company’s future performance through the grant of Awards. 
Capitalized terms not defined elsewhere in the text are defined in Section 28.

 

2.               SHARES SUBJECT TO THE PLAN.

 

2.1.              Number of Shares Available.  Subject to Section 2.4, Section 2.6 and Section 21 and any other applicable provisions
hereof, the total number of Shares reserved and available for grant and issuance pursuant to this Plan as of the date of adoption of the
Plan by the Board, is 2,000,000 Shares, plus (a) any reserved shares not issued or subject to outstanding grants under the Company’s
2011 Stock Incentive Plan (the “Prior Plan”) on the Effective Date, (b) shares that are subject to stock
options or other awards granted under the Prior Plan that cease to be subject to such stock options or other awards by forfeiture or otherwise
after the Effective Date, (c) shares issued under the Prior Plan before or after the Effective Date pursuant to the exercise of stock
options that are, after the Effective Date, forfeited, (d) shares issued under the Prior Plan that are repurchased by the Company
at the original issue price and (e) shares that are subject to stock options or other awards under the Prior Plan that are used to
pay the exercise price of an option or withheld to satisfy the tax withholding obligations related to any award.

 

2.2.              Lapsed, Returned Awards.  Shares subject to Awards, and Shares issued under the Plan under any Award, will again be available
for grant and issuance in connection with subsequent Awards under this Plan to the extent such Shares:  (a) are subject to issuance
upon exercise of an Option or SAR granted under this Plan but which cease to be subject to the Option or SAR for any reason other than
exercise of the Option or SAR; (b) are subject to Awards granted under this Plan that are forfeited or are repurchased by the Company
at the original issue price; (c) are subject to Awards granted under this Plan that otherwise terminate without such Shares being
issued; or (d) are surrendered pursuant to an Exchange Program.  To the extent an Award under the Plan is paid out in cash rather
than Shares, such cash payment will not result in reducing the number of Shares available for issuance under the Plan.  Shares used
to pay the exercise price of an Award or withheld to satisfy the tax withholding obligations related to an Award will become available
for future grant or sale under the Plan.  For the avoidance of doubt, Shares that otherwise become available for grant and issuance
because of the provisions of this Section 2.2 shall not include Shares subject to Awards that initially became available because
of the substitution clause in Section 21.2 hereof.

 

2.3.              
Minimum Share Reserve.  At all times the Company will reserve and keep available a sufficient number of Shares as will be
required to satisfy the requirements of all outstanding Awards granted under this Plan.

 

2.4.              
Automatic Share Reserve Increase.  The number of Shares available for grant and issuance under the Plan will be increased
on January 1 for each of the first ten (10) calendar years during the term of the Plan by the lesser of (a) five percent
(5%) of all classes of the Company’s common stock outstanding on each December 31 immediately prior to the date of increase
or (b) such number of Shares determined by the Board.

 

2.5.              
ISO Limitation.  No more than 2,000,000 Shares shall be issued pursuant to the exercise of ISOs (as defined below) under the
Plan.

 

2.6.       If,
by reason of an adjustment pursuant to this Section 2.6, a Participant’s Award Agreement or other agreement related to any
Award or the Shares subject to such Award covers additional or different shares of stock or securities, then such additional or different
shares, and the Award Agreement or such other agreement in respect thereof, will be subject to all of the terms, conditions and restrictions
which were applicable to the Award or the Shares subject to such Award prior to such adjustment.

 

3.               ELIGIBILITY.  ISOs may be granted only to Employees.  All other Awards may be granted to Employees, Consultants,
Directors and Non-Employee Directors; provided such Consultants and Non-Employee Directors render bona fide services not in connection
with the offer and sale of securities in a capital-raising transaction.

 

 

 

    	 	1	 

     

    

 

4.               ADMINISTRATION.

 

4.1.             Committee Composition; Authority.  This Plan will be administered by the Committee or by the Board acting as the Committee. 
Subject to the general purposes, terms and conditions of this Plan, and to the direction of the Board, the Committee will have full power
to implement and carry out this Plan, except, however, the Board will establish the terms for the grant of an Award to Non-Employee Directors. 
The Committee will have the authority to:

 

(a)                   
construe and interpret this Plan, any Award Agreement and any other agreement or document executed pursuant to this Plan;

 

(b)                    
prescribe, amend and rescind rules and regulations relating to this Plan or any Award;

 

(c)                    
select persons to receive Awards;

 

(d)                   
determine the form and terms and conditions, not inconsistent with the terms of the Plan, of any Award granted hereunder. Such terms and
conditions include, but are not limited to, the Exercise Price, the time or times when Awards may vest and be exercised (which may be
based on performance criteria) or settled, any vesting acceleration or waiver of forfeiture restrictions, the method to satisfy tax withholding
obligations or any other tax liability legally due and any restriction or limitation regarding any Award or the Shares relating thereto,
based in each case on such factors as the Committee will determine;

 

(e)                    
determine the number of Shares or other consideration subject to Awards;

 

(f)                     
determine the Fair Market Value in good faith and interpret the applicable provisions of this Plan and the definition of Fair Market Value
in connection with circumstances that impact the Fair Market Value, if necessary;

 

(g)                    
determine whether Awards will be granted singly, in combination with, in tandem with, in replacement of, or as alternatives to, other
Awards under this Plan or any other incentive or compensation plan of the Company or any Parent, Subsidiary or Affiliate;

 

(h)                   
grant waivers of Plan or Award conditions;

 

(i)                     
determine the vesting, exercisability and payment of Awards;

 

(j)                     
correct any defect, supply any omission or reconcile any inconsistency in this Plan, any Award or any Award Agreement;

 

(k)                   
determine whether an Award has been vested and/or earned;

 

(l)                    
determine the terms and conditions of any, and to institute any Exchange Program;

 

(m)                  
reduce, waive or modify any criteria with respect to Performance Factors;

 

(n)                   
adjust Performance Factors;

 

(o)                    
adopt terms and conditions, rules and/or procedures (including the adoption of any subplan under this Plan) relating to the operation
and administration of the Plan to accommodate requirements of local law and procedures outside of the United States or to qualify Awards
for special tax treatment under laws of jurisdictions other than the United States;

 

(p)                   
exercise discretion with respect to Performance Awards;

 

 

 

    	 	2	 

     

    

 

(q)                   
make all other determinations necessary or advisable for the administration of this Plan; and

 

(r)                    
delegate any of the foregoing to a subcommittee or to one or more executive officers pursuant to a specific delegation as permitted by
applicable law.

 

4.2.              
Committee Interpretation and Discretion.  Any determination made by the Committee with respect to any Award will be made
in its sole discretion at the time of grant of the Award or, unless in contravention of any express term of the Plan or Award, at any
later time, and such determination will be final and binding on the Company and all persons having an interest in any Award under the
Plan.  Any dispute regarding the interpretation of the Plan or any Award Agreement will be submitted by the Participant or Company
to the Committee for review.  The resolution of such a dispute by the Committee will be final and binding on the Company and the
Participant.  The Committee may delegate to one or more executive officers the authority to review and resolve disputes with respect
to Awards held by Participants who are not Insiders, and such resolution will be final and binding on the Company and the Participant.

 

4.3.              
Section 16 of the Exchange Act.  Awards granted to Participants who are subject to Section 16 of the Exchange Act
must be approved by two or more “non-employee directors” (as defined in the regulations promulgated under Section 16
of the Exchange Act).

 

4.4.              
Documentation.  The Award Agreement for a given Award, the Plan and any other documents may be delivered to, and accepted
by, a Participant or any other person in any manner (including electronic distribution or posting) that meets applicable legal requirements.

 

4.5.              
Foreign Award Recipients.  Notwithstanding any provision of the Plan to the contrary, in order to comply with the laws and
practices in other countries in which the Company and its Subsidiaries or Affiliates operate or have Employees or other individuals eligible
for Awards, the Committee, in its sole discretion, will have the power and authority to:  (a) determine which Subsidiaries and Affiliates
will be covered by the Plan; (b) determine which individuals outside the United States are eligible to participate in the Plan; (c) modify
the terms and conditions of any Award granted to individuals outside the United States or foreign nationals to comply with applicable
foreign laws, policies, customs and practices; (d) establish subplans and modify exercise procedures, vesting conditions, and other terms
and procedures, to the extent the Committee determines such actions to be necessary or advisable (and such subplans and/or modifications
will be attached to this Plan as appendices, if necessary); provided, however, that no such subplans and/or modifications will increase
the share limitations contained in Section 2.1 hereof; and (e) take any action, before or after an Award is made, that the Committee determines
to be necessary or advisable to obtain approval or comply with any local governmental regulatory exemptions or approvals.  Notwithstanding
the foregoing, the Committee may not take any actions hereunder, and no Awards will be granted, that would violate the Exchange Act or
any other applicable United States securities law, the Code, or any other applicable United States governing statute or law.

 

5.              OPTIONS.  An Option is the right but not the obligation to purchase a Share, subject to certain conditions, if applicable. 
The Committee may grant Options to eligible Employees, Consultants and Directors and will determine whether such Options will be Incentive
Stock Options within the meaning of the Code (“ISOs”) or Nonqualified Stock Options (“NSOs”),
the number of Shares subject to the Option, the Exercise Price of the Option, the period during which the Option may vest and be exercised,
and all other terms and conditions of the Option, subject to the following terms of this section.

 

5.1.                Option Grant.  Each Option granted under this Plan will identify the Option as an ISO or an NSO.  An Option may be, but
need not be, awarded upon satisfaction of such Performance Factors during any Performance Period as are set out in advance in the Participant’s
individual Award Agreement.  If the Option is being earned upon the satisfaction of Performance Factors, then the Committee will:
(a) determine the nature, length and starting date of any Performance Period for each Option; and (b) select from among the
Performance Factors to be used to measure the performance, if any.  Performance Periods may overlap and Participants may participate
simultaneously with respect to Options that are subject to different performance goals and other criteria.

 

5.2.               Date of Grant.  The date of grant of an Option will be the date on which the Committee makes the determination to grant such
Option, or a specified future date.  The Award Agreement will be delivered to the Participant within a reasonable time after the
granting of the Option.

 

 

 

    	 	3	 

     

    

 

5.3.                Exercise Period.  Options may be vested and exercisable within the times or upon the conditions as set forth in the Award
Agreement governing such Option; provided, however, that no Option will be exercisable after the expiration of ten (10) years from
the date the Option is granted; and provided further that no ISO granted to a person who, at the time the ISO is granted, directly or
by attribution owns more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or of any Parent
or Subsidiary (“Ten Percent Stockholder”) will be exercisable after the expiration of five (5) years from
the date the ISO is granted.  The Committee also may provide for Options to become exercisable at one time or from time to time,
periodically or otherwise, in such number of Shares or percentage of Shares as the Committee determines.

 

5.4.                Exercise Price.  The Exercise Price of an Option will be determined by the Committee when the Option is granted; provided
that: (a) the Exercise Price of an Option will be not less than one hundred percent (100%) of the Fair Market Value of the Shares
on the date of grant and (b) the Exercise Price of any ISO granted to a Ten Percent Stockholder will not be less than one hundred
ten percent (110%) of the Fair Market Value of the Shares on the date of grant.  Payment for the Shares purchased may be made in
accordance with Section 11 and the Award Agreement and in accordance with any procedures established by the Company.

  

5.5.               Method of Exercise.  Any Option granted hereunder will be vested and exercisable according to the terms of the Plan and at
such times and under such conditions as determined by the Committee and set forth in the Award Agreement. An Option may not be exercised
for a fraction of a Share. An Option will be deemed exercised when the Company receives: (a) notice of exercise (in such form as
the Committee may specify from time to time) from the person entitled to exercise the Option (and/or via electronic execution through
the authorized third-party administrator), and (b) full payment for the Shares with respect to which the Option is exercised (together
with applicable withholding taxes). Full payment may consist of any consideration and method of payment authorized by the Committee and
permitted by the Award Agreement and the Plan. Shares issued upon exercise of an Option will be issued in the name of the Participant.
Until the Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent
of the Company), no right to vote or receive dividends or any other rights as a stockholder will exist with respect to the Shares, notwithstanding
the exercise of the Option. The Company will issue (or cause to be issued) such Shares promptly after the Option is exercised.  No
adjustment will be made for a dividend or other right for which the record date is prior to the date the Shares are issued, except as
provided in Section 2.6 of the Plan. Exercising an Option in any manner will decrease the number of Shares thereafter available,
both for purposes of the Plan and for sale under the Option, by the number of Shares as to which the Option is exercised.

 

5.6.              Termination
of Service.  If the Participant’s Service terminates for any reason except for Cause or the Participant’s death or Disability,
then the Participant may exercise such Participant’s Options only to the extent that such Options would have been exercisable by
the Participant on the date Participant’s Service terminates no later than three (3) months after the date Participant’s
Service terminates (or such shorter or longer time period as may be determined by the Committee, with any exercise beyond three (3) months
after the date Participant’s employment terminates deemed to be the exercise of an NSO), but in any event no later than the expiration
date of the Options.

 

(a)                   
Death.  If the Participant’s Service terminates because of the Participant’s death (or the Participant dies within
three (3) months after Participant’s Service terminates other than for Cause or because of the Participant’s Disability),
then the Participant’s Options may be exercised only to the extent that such Options would have been exercisable by the Participant
on the date Participant’s Service terminates and must be exercised by the Participant’s legal representative, or authorized
assignee, no later than twelve (12) months after the date Participant’s Service terminates (or such shorter time period or longer
time period as may be determined by the Committee), but in any event no later than the expiration date of the Options.

 

(b)                   
Disability.  If the Participant’s Service terminates because of the Participant’s Disability, then the Participant’s
Options may be exercised only to the extent that such Options would have been exercisable by the Participant on the date Participant’s
Service terminates and must be exercised by the Participant (or the Participant’s legal representative or authorized assignee) no
later than twelve (12) months after the date Participant’s Service terminates (or such shorter or longer time period as may be determined
by the Committee, with any exercise beyond (a) three (3) months after the date Participant’s employment terminates when
the termination of Service is for a Disability that is not a “permanent and total disability” as defined in Section 22(e)(3) of
the Code, or (b) twelve (12) months after the date Participant’s employment terminates when the termination of Service is for
a Disability that is a “permanent and total disability” as defined in Section 22(e)(3) of the Code, deemed to be
exercise of an NSO), but in any event no later than the expiration date of the Options.

 

 

 

    	 	4	 

     

    

 

(c)                   
Cause.  If the Participant’s Service terminates for Cause, then Participant’s Options (whether or not vested)
will expire on the date of termination of Participant’s Service if the Committee has reasonably determined in good faith that such
cessation of Services has resulted in connection with an act or failure to act constituting Cause (or such Participant’s Services
could have been terminated for Cause (without regard to the lapsing of any required notice or cure periods in connection therewith) at
the time such Participant terminated Services), or at such later time and on such conditions as are determined by the Committee, but in
any event no later than the expiration date of the Options.  Unless otherwise provided in an employment agreement, Award Agreement,
or other applicable agreement, Cause will have the meaning set forth in the Plan.

 

5.7.               Limitations
on Exercise.  The Committee may specify a minimum number of Shares that may be purchased on any exercise of an Option, provided
that such minimum number will not prevent any Participant from exercising the Option for the full number of Shares for which it is then
exercisable.

 

5.8.              Limitations on ISOs.  With respect to Awards granted as ISOs, to the extent that the aggregate Fair Market Value of the Shares
with respect to which such ISOs are exercisable for the first time by the Participant during any calendar year (under all plans of the
Company and any Parent or Subsidiary) exceeds one hundred thousand dollars ($100,000), such Options will be treated as NSOs. For purposes
of this Section 5.8, ISOs will be taken into account in the order in which they were granted. The Fair Market Value of the Shares
will be determined as of the time the Option with respect to such Shares is granted.  In the event that the Code or the regulations
promulgated thereunder are amended after the Effective Date to provide for a different limit on the Fair Market Value of Shares permitted
to be subject to ISOs, such different limit will be automatically incorporated herein and will apply to any Options granted after the
effective date of such amendment.

 

5.9.               Modification, Extension or Renewal.  The Committee may modify, extend or renew outstanding Options and authorize the grant
of new Options in substitution therefor, provided that any such action may not, without the written consent of a Participant, impair any
of such Participant’s rights under any Option previously granted.  Any outstanding ISO that is modified, extended, renewed
or otherwise altered will be treated in accordance with Section 424(h) of the Code.  Subject to Section 18 of this
Plan, by written notice to affected Participants, the Committee may reduce the Exercise Price of outstanding Options without the consent
of such Participants; provided, however, that the Exercise Price may not be reduced below the Fair Market Value on the date
the action is taken to reduce the Exercise Price.

 

5.10.            No Disqualification.  Notwithstanding any other provision in this Plan, no term of this Plan relating to ISOs will be interpreted,
amended or altered, nor will any discretion or authority granted under this Plan be exercised, so as to disqualify this Plan under Section 422
of the Code or, without the consent of the Participant affected, to disqualify any ISO under Section 422 of the Code.

 

6.             RESTRICTED STOCK AWARDS.  A Restricted Stock Award (“RSA”) is an offer by the Company to
sell to an eligible Employee, Consultant, or Director Shares that are subject to restrictions (“Restricted Stock”). 
The Committee will determine to whom an offer will be made, the number of Shares the Participant may purchase, the Purchase Price,
the restrictions under which the Shares will be subject and all other terms and conditions of the Restricted Stock Award, subject to the
Plan.

 

6.1.              Restricted Stock Purchase Agreement.  All purchases under a Restricted Stock Award will be evidenced by an Award
Agreement.  Except as may otherwise be provided in an Award Agreement, a Participant accepts a Restricted Stock Award by signing
and delivering to the Company an Award Agreement with full payment of the Purchase Price, within thirty (30) days from the date the Award
Agreement was delivered to the Participant.  If the Participant does not accept such Award within thirty (30) days, then the offer
of such Restricted Stock Award will terminate, unless the Committee determines otherwise.

 

6.2.              
Purchase Price.  The Purchase Price for a Restricted Stock Award will be determined by the Committee and may be less
than Fair Market Value on the date the Restricted Stock Award is granted.  Payment of the Purchase Price must be made in accordance
with Section 11 of the Plan, and the Award Agreement and in accordance with any procedures established by the Company.

  

6.3.              
Terms of Restricted Stock Awards.  Restricted Stock Awards will be subject to such restrictions as the Committee may impose
or are required by law. These restrictions may be based on completion of a specified number of years of service with the Company
or upon completion of Performance Factors, if any, during any Performance Period as set out in advance in the Participant’s Award
Agreement.  Prior to the grant of a Restricted Stock Award, the Committee shall: (a) determine the nature, length and starting
date of any Performance Period for the Restricted Stock Award; (b) select from among the Performance Factors to be used to measure
performance goals, if any; and (c) determine the number of Shares that may be awarded to the Participant.  Performance Periods
may overlap and a Participant may participate simultaneously with respect to Restricted Stock Awards that are subject to different Performance
Periods and having different performance goals and other criteria.

 

 

 

    	 	5	 

     

    

 

6.4.              
Termination of Service.  Except as may be set forth in the Participant’s Award Agreement, vesting ceases on such date
Participant’s Service terminates (unless determined otherwise by the Committee).

 

7.           STOCK BONUS AWARDS.  A Stock Bonus Award is an award to an eligible Employee, Consultant, or Director of Shares for
Services to be rendered or for past Services already rendered to the Company or any Parent, Subsidiary or Affiliate.  All Stock Bonus
Awards shall be made pursuant to an Award Agreement.  No payment from the Participant will be required for Shares awarded pursuant
to a Stock Bonus Award.

 

7.1.              Terms
of Stock Bonus Awards.  The Committee will determine the number of Shares to be awarded to the Participant under a Stock Bonus Award
and any restrictions thereon.  These restrictions may be based upon completion of a specified number of years of service with the
Company or upon satisfaction of performance goals based on Performance Factors during any Performance Period as set out in advance in
the Participant’s Stock Bonus Agreement.  Prior to the grant of any Stock Bonus Award the Committee shall: (a) determine
the nature, length and starting date of any Performance Period for the Stock Bonus Award; (b) select from among the Performance
Factors to be used to measure performance goals; and (c) determine the number of Shares that may be awarded to the Participant. 
Performance Periods may overlap and a Participant may participate simultaneously with respect to Stock Bonus Awards that are subject
to different Performance Periods and different performance goals and other criteria.

 

7.2.               Form of Payment to Participant.  Payment may be made in the form of cash, whole Shares, or a combination thereof, based
on the Fair Market Value of the Shares earned under a Stock Bonus Award on the date of payment, as determined in the sole discretion of
the Committee.

 

7.3.                           
Termination of Service.  Except as may be set forth in the Participant’s Award Agreement, vesting ceases on such date
Participant’s Service terminates (unless determined otherwise by the Committee).

 

8.             STOCK APPRECIATION RIGHTS.  A Stock Appreciation Right (“SAR”) is an award to an eligible
Employee, Consultant, or Director that may be settled in cash, or Shares (which may consist of Restricted Stock), having a value equal
to (a) the difference between the Fair Market Value on the date of exercise over the Exercise Price multiplied by (b) the number
of Shares with respect to which the SAR is being settled (subject to any maximum number of Shares that may be issuable as specified in
an Award Agreement).  All SARs shall be made pursuant to an Award Agreement.

 

8.1.              Terms of SARs.  The Committee will determine the terms of each SAR including, without limitation: (a) the number of Shares
subject to the SAR; (b) the Exercise Price and the time or times during which the SAR may be settled; (c) the consideration
to be distributed on settlement of the SAR; and (d) the effect of the Participant’s termination of Service on each SAR. 
The Exercise Price of the SAR will be determined by the Committee when the SAR is granted, and may not be less than Fair Market Value. 
A SAR may be awarded upon satisfaction of Performance Factors, if any, during any Performance Period as are set out in advance in the
Participant’s individual Award Agreement.  If the SAR is being earned upon the satisfaction of Performance Factors, then the
Committee will: (x) determine the nature, length and starting date of any Performance Period for each SAR; and (y) select from
among the Performance Factors to be used to measure the performance, if any.  Performance Periods may overlap and Participants may
participate simultaneously with respect to SARs that are subject to different Performance Factors and other criteria.

 

8.2.              Exercise Period and Expiration Date.  A SAR will be exercisable within the times or upon the occurrence of events determined
by the Committee and set forth in the Award Agreement governing such SAR.  The SAR Agreement shall set forth the expiration date;
provided that no SAR will be exercisable after the expiration of ten (10) years from the date the SAR is granted.  The Committee
may also provide for SARs to become exercisable at one time or from time to time, periodically or otherwise (including, without limitation,
upon the attainment during a Performance Period of performance goals based on Performance Factors), in such number of Shares or percentage
of the Shares subject to the SAR as the Committee determines.  Except as may be set forth in the Participant’s Award Agreement,
vesting ceases on the date Participant’s Service terminates (unless determined otherwise by the Committee).  Notwithstanding
the foregoing, the rules of Section 5.6 also will apply to SARs.

 

8.3.              Form of Settlement.  Upon exercise of a SAR, a Participant will be entitled to receive payment from the Company in an
amount determined by multiplying (a) the difference between the Fair Market Value of a Share on the date of exercise over the Exercise
Price; times (b) the number of Shares with respect to which the SAR is exercised. At the discretion of the Committee, the payment
from the Company for the SAR exercise may be in cash, in Shares of equivalent value, or in some combination thereof.  The portion
of a SAR being settled may be paid currently or on a deferred basis with such interest, if any, as the Committee determines, provided
that the terms of the SAR and any deferral satisfy the requirements of Section 409A of the Code to the extent applicable.

 

 

 

    	 	6	 

     

    

 

8.4.              Termination of Service.  Except as may be set forth in the Participant’s Award Agreement, vesting ceases on such date
Participant’s Service terminates (unless determined otherwise by the Committee).

 

9.              RESTRICTED STOCK UNITS.  A Restricted Stock Unit (“RSU”) is an award to an eligible Employee,
Consultant, or Director covering a number of Shares that may be settled in cash, or by issuance of those Shares (which may consist of
Restricted Stock).  All RSUs shall be made pursuant to an Award Agreement.

 

9.1.              Terms of RSUs.  The Committee will determine the terms of an RSU including, without limitation: (a) the number of Shares
subject to the RSU; (b) the time or times during which the RSU may be settled; (c) the consideration to be distributed on settlement;
and (d) the effect of the Participant’s termination of Service on each RSU; provided that no RSU shall have a term longer than
ten (10) years.  An RSU may be awarded upon satisfaction of such performance goals based on Performance Factors during any Performance
Period as are set out in advance in the Participant’s Award Agreement.  If the RSU is being earned upon satisfaction of Performance
Factors, then the Committee will: (x) determine the nature, length and starting date of any Performance Period for the RSU; (y) select
from among the Performance Factors to be used to measure the performance, if any; and (z) determine the number of Shares deemed subject
to the RSU.  Performance Periods may overlap and Participants may participate simultaneously with respect to RSUs that are subject
to different Performance Periods and different performance goals and other criteria.

 

9.2.              Form and
Timing of Settlement.  Payment of earned RSUs shall be made as soon as practicable after the date(s) determined by the Committee
and set forth in the Award Agreement. The Committee, in its sole discretion, may settle earned RSUs in cash, Shares, or a combination
of both.  The Committee may also permit a Participant to defer payment under a RSU to a date or dates after the RSU earned provided
that the terms of the RSU and any deferral satisfy the requirements of Section 409A of the Code to the extent applicable.

 

9.3.                Termination of Service.  Except as may be set forth in the Participant’s Award Agreement, vesting ceases on such date
Participant’s Service terminates (unless determined otherwise by the Committee).

 

10.           PERFORMANCE AWARDS.  A Performance Award is an award to an eligible Employee, Consultant, or Director of the Company
or any Parent, Subsidiary or Affiliate that is based upon the attainment of performance goals, as established by the Committee, and other
terms and conditions specified by the Committee, and may be settled in cash, Shares (which may consist of, without limitation, Restricted
Stock), other property, or any combination thereof.  Grants of Performance Awards shall be made pursuant to an Award Agreement.

 

10.1.            Performance Awards shall include Performance Shares, Performance Units, and cash-based Awards as set forth in Sections 10.1(a), 10.1(b),
and 10.1(c) below.

 

(a)                   
Performance Shares.  The Committee may grant Awards of Performance Shares, designate the Participants to whom Performance
Shares are to be awarded and determine the number of Performance Shares and the terms and conditions of each such Award. Performance Shares
shall consist of a unit valued by reference to a designated number of Shares, the value of which may be paid to the Participant by delivery
of Shares or, if set forth in the instrument evidencing the Award, of such property as the Committee shall determine, including, without
limitation, cash, Shares, other property, or any combination thereof, upon the attainment of performance goals, as established by the
Committee, and other terms and conditions specified by the Committee.  The amount to be paid under an Award of Performance Shares
may be adjusted on the basis of such further consideration as the Committee shall determine in its sole discretion.

 

(b)                   
Performance Units.  The Committee may grant Awards of Performance Units, designate the Participants to whom Performance Units
are to be awarded and determine the number of Performance Units and the terms and conditions of each such Award. Performance Units shall
consist of a unit valued by reference to a designated amount of property other than Shares, which value may be paid to the Participant
by delivery of such property as the Committee shall determine, including, without limitation, cash, Shares, other property, or any combination
thereof, upon the attainment of performance goals, as established by the Committee, and other terms and conditions specified by the Committee.

 

 

 

    	 	7	 

     

    

 

(c)                    
Cash-Settled Performance Awards.  The Committee may grant cash-settled Performance Awards to Participants under the terms
of this Plan. Such awards will be based on the attainment of performance goals using the Performance Factors within this Plan that are
established by the Committee for the relevant performance period.

 

10.2.           Terms
of Performance Awards.  Performance Awards will be based on the attainment of performance goals using the Performance Factors within
this Plan that are established by the Committee for the relevant Performance Period.  The Committee will determine, and each Award
Agreement shall set forth, the terms of each Performance Award including, without limitation: (a) the amount of any cash bonus,
(b) the number of Shares deemed subject to an award of Performance Shares; (c) the Performance Factors and Performance Period
that shall determine the time and extent to which each award of Performance Shares shall be settled; (d) the consideration to be
distributed on settlement, and (e) the effect of the Participant’s termination of Service on each Performance Award. 
In establishing Performance Factors and the Performance Period the Committee will: (x) determine the nature, length and starting
date of any Performance Period; (y) select from among the Performance Factors to be used; and (z) determine the number of Shares
deemed subject to the award of Performance Shares.  Prior to settlement the Committee shall determine the extent to which Performance
Awards have been earned.  Performance Periods may overlap and Participants may participate simultaneously with respect to Performance
Awards that are subject to different Performance Periods and different performance goals and other criteria.

 

10.3.            Termination of Service.  Except as may be set forth in the Participant’s Award Agreement, vesting ceases on the date
Participant’s Service terminates (unless determined otherwise by the Committee).

 

11.             PAYMENT FOR SHARE PURCHASES.  Payment from a Participant for Shares purchased pursuant to this Plan may be made in
cash or by check or, where approved for the Participant by the Committee and where permitted by law (and to the extent not otherwise set
forth in the applicable Award Agreement):

 

(a)                  
by cancellation of indebtedness of the Company to the Participant;

 

(b)                  
by surrender of shares of the Company held by the Participant that have a Fair Market Value on the date of surrender equal to the aggregate
exercise price of the Shares as to which said Award will be exercised or settled;

 

(c)                    by waiver of compensation due or accrued to the Participant for services rendered or to be rendered to the Company or a Parent or Subsidiary;

 

(d)                    by consideration received by the Company pursuant to a broker-assisted or other form of cashless exercise program implemented by the Company
in connection with the Plan;

 

(e)                     by any combination of the foregoing; or

 

(f)                     
by any other method of payment as is permitted by applicable law.

 

12.             GRANTS TO NON-EMPLOYEE DIRECTORS.

 

12.1.            Grant
and Eligibility.  Awards under the Plan may be granted to Non-Employee Directors may be automatically made pursuant to a policy
adopted by the Board, or made from time to time as determined in the discretion of the Board.

 

12.2.            Vesting,
Exercisability and Settlement.  Except as set forth in Section 21, Awards will vest, become exercisable and be settled as determined
by the Board.  With respect to Options and SARs, the exercise price granted to Non-Employee Directors will not be less than the
Fair Market Value of the Shares at the time that such Option or SAR is granted.

 

 

    	 	8	 

     

    

 

12.3.             Election to Receive Awards in Lieu of Cash.  A Non-Employee Director may elect to receive his or her annual retainer payments
and/or meeting fees from the Company in the form of cash or Awards or a combination thereof, if permitted, and as determined, by the Committee. 
Such Awards shall be issued under the Plan.  An election under this Section 12.3 shall be filed with the Company on the form
prescribed by the Company.

 

13.           
WITHHOLDING TAXES.

 

13.1.             Withholding Generally.  Whenever Shares are to be issued in satisfaction of Awards granted under this Plan or a tax event
occurs, the Company may require the Participant to remit to the Company, or to the Parent, Subsidiary or Affiliate, as applicable, 
employing the Participant, an amount sufficient to satisfy applicable U.S. federal, state, local and international tax or any other
tax or social insurance liability (the “Tax-Related Items”) required to be withheld from the Participant prior
to the delivery of Shares pursuant to exercise or settlement of any Award.  Whenever payments in satisfaction of Awards granted under
this Plan are to be made in cash, such payment will be net of an amount sufficient to satisfy applicable withholding obligations for Tax-Related
Items.  Unless otherwise determined by the Committee, the Fair Market Value of the Shares will be determined as of the date that
the taxes are required to be withheld and such Shares will be valued based on the value of the actual trade or, if there is none, the
Fair Market Value of the Shares as of the previous trading day.

 

13.2.            Stock Withholding.  The Committee, or its delegate(s), as permitted by applicable law, in its sole discretion and pursuant
to such procedures as it may specify from time to time and to limitations of local law, may require or permit a Participant to satisfy
such Tax Related Items legally due from the Participant, in whole or in part by (without limitation) (a) paying cash, (b) having
the Company withhold otherwise deliverable cash or Shares having a Fair Market Value equal to the Tax-Related Items to be withheld, (c) delivering
to the Company already-owned shares having a Fair Market Value equal to the Tax-Related Items to be withheld or (d) withholding from
the proceeds of the sale of otherwise deliverable Shares acquired pursuant to an Award either through a voluntary sale or through a mandatory
sale arranged by the Company.  The Company may withhold or account for these Tax-Related Items by considering applicable statutory
withholding rates or other applicable withholding rates, including up to (but not in excess of) the maximum permissible statutory tax
rate for the applicable tax jurisdiction, to the extent consistent with applicable laws.

 

14.           TRANSFERABILITY.  Unless determined otherwise by the Committee, an Award may not be sold, pledged, assigned, hypothecated,
transferred, or disposed of in any manner other than by will or by the laws of descent or distribution.  If the Committee makes an
Award transferable, including, without limitation, by instrument to an inter vivos or testamentary trust in which the Awards are to be
passed to beneficiaries upon the death of the trustor (settlor) or by gift or by domestic relations order to a Permitted Transferee, such
Award will contain such additional terms and conditions as the Committee deems appropriate.  All Awards will be exercisable: (a) during
the Participant’s lifetime only by the Participant, or the Participant’s guardian or legal representative; (b) after
the Participant’s death, by the legal representative of the Participant’s heirs or legatees; and (c) in the case of all
awards except ISOs, by a Permitted Transferee.

 

15.           PRIVILEGES OF STOCK OWNERSHIP; RESTRICTIONS ON SHARES.

 

15.1.            Voting
and Dividends.  No Participant will have any of the rights of a stockholder with respect to any Shares until the Shares are issued
to the Participant, except for any Dividend Equivalent Rights permitted by an applicable Award Agreement. Any Dividend Equivalent Rights
will be subject to the same vesting or performance conditions as the underlying Award.  In addition, the Committee may provide that
any Dividend Equivalent Rights permitted by an applicable Award Agreement will be deemed to have been reinvested in additional Shares
or otherwise reinvested.  After Shares are issued to the Participant, the Participant will be a stockholder and have all the rights
of a stockholder with respect to such Shares, including the right to vote and receive all dividends or other distributions made or paid
with respect to such Shares; provided, that if such Shares are Restricted Stock, then any new, additional or different securities
the Participant may become entitled to receive with respect to such Shares by virtue of a stock dividend, stock split or any other change
in the corporate or capital structure of the Company will be subject to the same restrictions as the Restricted Stock; provided,
further, that the Participant will have no right to such stock dividends or stock distributions with respect to Unvested Shares,
and any such dividends or stock distributions will be accrued and paid only at such time, if any, as such Unvested Shares become vested
Shares.  The Committee, in its discretion, may provide in the Award Agreement evidencing any Award that the Participant will be
entitled to Dividend Equivalent Rights with respect to the payment of cash dividends on Shares underlying an Award during the period
beginning on the date the Award is granted and ending, with respect to each Share subject to the Award, on the earlier of the date on
which the Award is exercised or settled or the date on which it is forfeited provided, that no Dividend Equivalent Right will
be paid with respect to the Unvested Shares, and such dividends or stock distributions will be accrued and paid only at such time, if
any, as such Unvested Shares become vested Shares. Such Dividend Equivalent Rights, if any, will be credited to the Participant in the
form of additional whole Shares as of the date of payment of such cash dividends on Shares.

 

 

 

    	 	9	 

     

    

 

15.2.            Restrictions on Shares.  At the discretion of the Committee, the Company may reserve to itself and/or its assignee(s) a
right to repurchase (a “Right of Repurchase”) a portion of any or all Unvested Shares held by a Participant
following such Participant’s termination of Service at any time within ninety (90) days (or such longer or shorter time determined
by the Committee) after the later of the date Participant’s Service terminates and the date the Participant purchases Shares under
this Plan, for cash and/or cancellation of purchase money indebtedness, at the Participant’s Purchase Price or Exercise Price, as
the case may be.

 

16.            CERTIFICATES.  All Shares or other securities whether or not certificated, delivered under this Plan will be subject
to such stock transfer orders, legends and other restrictions as the Committee may deem necessary or advisable, including restrictions
under any applicable U.S. federal, state or foreign securities law, or any rules, regulations and other requirements of the SEC or any
stock exchange or automated quotation system upon which the Shares may be listed or quoted and any non-U.S. exchange controls or securities
law restrictions to which the Shares are subject.

 

17.             ESCROW; PLEDGE OF SHARES.  To enforce any restrictions on a Participant’s Shares, the Committee may require the
Participant to deposit all certificates representing Shares, together with stock powers or other instruments of transfer approved by the
Committee, appropriately endorsed in blank, with the Company or an agent designated by the Company to hold in escrow until such restrictions
have lapsed or terminated, and the Committee may cause a legend or legends referencing such restrictions to be placed on the certificates. 
Any Participant who is permitted to execute a promissory note as partial or full consideration for the purchase of Shares under this Plan
will be required to pledge and deposit with the Company all or part of the Shares so purchased as collateral to secure the payment of
the Participant’s obligation to the Company under the promissory note; provided, however, that the Committee may require
or accept other or additional forms of collateral to secure the payment of such obligation and, in any event, the Company will have full
recourse against the Participant under the promissory note notwithstanding any pledge of the Participant’s Shares or other collateral. 
In connection with any pledge of the Shares, the Participant will be required to execute and deliver a written pledge agreement in such
form as the Committee will from time to time approve.  The Shares purchased with the promissory note may be released from the pledge
on a pro rata basis as the promissory note is paid.

 

18.             REPRICING; EXCHANGE AND BUYOUT OF AWARDS.  Without prior stockholder approval, the Committee may (a) reprice Options
or SARs (and where such repricing is a reduction in the Exercise Price of outstanding Options or SARs, the consent of the affected Participants
is not required provided written notice is provided to them, notwithstanding any adverse tax consequences to them arising from the repricing),
and (b) with the consent of the respective Participants (unless not required pursuant to Section 5.9 of the Plan), pay cash
or issue new Awards in exchange for the surrender and cancellation of any, or all, outstanding Awards.

 

19.             SECURITIES LAW AND OTHER REGULATORY COMPLIANCE.  An Award will not be effective unless such Award is in compliance
with all applicable U.S. and foreign federal and state securities and exchange control laws, rules and regulations of any governmental
body, and the requirements of any stock exchange or automated quotation system upon which the Shares may then be listed or quoted, as
they are in effect on the date of grant of the Award and also on the date of exercise or other issuance.  Notwithstanding any other
provision in this Plan, the Company will have no obligation to issue or deliver certificates for Shares under this Plan prior to: (a) obtaining
any approvals from governmental agencies that the Company determines are necessary or advisable; and/or (b) completion of any registration
or other qualification of such Shares under any state or federal or foreign law or ruling of any governmental body that the Company determines
to be necessary or advisable.  The Company will be under no obligation to register the Shares with the SEC or to effect compliance
with the registration, qualification or listing requirements of any foreign or state securities laws, exchange control laws, stock exchange
or automated quotation system, and the Company will have no liability for any inability or failure to do so.

 

20.            NO OBLIGATION TO EMPLOY.  Nothing in this Plan or any Award granted under this Plan will confer or be deemed to confer
on any Participant any right to continue in the employ of, or to continue any other relationship with, the Company or any Parent, Subsidiary
or Affiliate or limit in any way the right of the Company or any Parent, Subsidiary or Affiliate to terminate Participant’s employment
or other relationship at any time.

 

 

 

    	 	10	 

     

    

 

21.            CORPORATE TRANSACTIONS.

 

21.1.             Assumption or Replacement of Awards by Successor. In the event of a Corporate Transaction any or all outstanding
Awards may be (a) continued by the Company, if the Company is the successor entity; or (b) assumed or substituted by the successor
corporation, or a parent or subsidiary of the successor corporation, for substantially equivalent Awards (including, but not limited to,
an award to acquire the same consideration paid to the stockholders of the Company pursuant to the Corporate Transaction), in each case
after taking into account appropriate adjustments for the number and kind of shares and exercise prices. The successor corporation may
also issue, as replacement of outstanding Shares of the Company held by the Participant, substantially similar shares or other property
subject to repurchase restrictions no less favorable to the Participant.  In the event such successor corporation refuses to assume,
substitute or replace any Award in accordance with this Section 21, then notwithstanding any other provision in this Plan to the
contrary, each such Award shall become fully vested and, as applicable, exercisable and any rights of repurchase or forfeiture restrictions
thereon shall lapse, immediately prior to the consummation of the Corporation Transaction.  Performance Awards not assumed pursuant
to the foregoing shall be deemed earned and vested based on the greater of actual performance (if determinable) or 100% of target level,
unless otherwise indicated pursuant to the terms and conditions of the applicable Award Agreement.

 

If an Award vests in lieu of assumption or substitution
in connection with a Corporate Transaction as provided above, the Committee will notify the holder of such Award in writing or electronically
that such Award will be exercisable for a period of time determined by the Committee in its sole discretion, and such Award will terminate
upon the expiration of such period without consideration.  Any determinations by the Committee need not treat all outstanding Awards
in an identical manner, and shall be final and binding on each applicable Participant.

 

21.2.            Assumption of Awards by the Company.  The Company, from time to time, also may substitute or assume outstanding awards granted
by another company, whether in connection with an acquisition of such other company or otherwise, by either; (a) granting an Award
under this Plan in substitution of such other company’s award; or (b) assuming such award as if it had been granted under this
Plan if the terms of such assumed award could be applied to an Award granted under this Plan.  Such substitution or assumption will
be permissible if the holder of the substituted or assumed award would have been eligible to be granted an Award under this Plan if the
other company had applied the rules of this Plan to such grant.  In the event the Company assumes an award granted by another
company, the terms and conditions of such award will remain unchanged (except that the Purchase Price or the Exercise Price, as
the case may be, and the number and nature of Shares issuable upon exercise or settlement of any such Award will be adjusted appropriately
pursuant to Section 424(a) of the Code).  In the event the Company elects to grant a new Option in substitution rather
than assuming an existing option, such new Option may be granted with a similarly adjusted Exercise Price.  Substitute Awards will
not reduce the number of Shares authorized for grant under the Plan or authorized for grant to a Participant in a calendar year.

 

21.3.            Non-Employee
Directors’ Awards.  Notwithstanding any provision to the contrary herein, in the event of a Corporate Transaction, the vesting
of all Awards granted to Non-Employee Directors will accelerate and such Awards will become exercisable (as applicable) in full prior
to the consummation of such event at such times and on such conditions as the Committee determines.

 

22.             ADOPTION AND STOCKHOLDER APPROVAL.  This Plan will be submitted for the approval of the Company’s stockholders,
consistent with applicable laws, within twelve (12) months before or after the date this Plan is adopted by the Board.

 

23.            
TERM OF PLAN/GOVERNING LAW.  Unless earlier terminated as provided herein, this Plan will become effective on the Effective
Date and will terminate ten (10) years from the date this Plan is adopted by the Board.  This Plan and all Awards granted hereunder
will be governed by and construed in accordance with the laws of the State of Delaware (excluding its conflict of laws rules).

 

24.            AMENDMENT OR TERMINATION OF PLAN.  The Board may at any time terminate or amend this Plan in any respect, including,
without limitation, amendment of any form of Award Agreement or instrument to be executed pursuant to this Plan; provided, however,
that the Board will not, without the approval of the stockholders of the Company, amend this Plan in any manner that requires such stockholder
approval; provided further, that a Participant’s Award will be governed by the version of this Plan then in effect at the
time such Award was granted.  No termination or amendment of the Plan or any outstanding Award may adversely affect any then outstanding
Award without the consent of the Participant, unless such termination or amendment is necessary to comply with applicable law, regulation
or rule.

 

 

 

    	 	11	 

     

    

 

25.            
NONEXCLUSIVITY OF THE PLAN.  Neither the adoption of this Plan by the Board, the submission of this Plan to the stockholders
of the Company for approval, nor any provision of this Plan will be construed as creating any limitations on the power of the Board to
adopt such additional compensation arrangements as it may deem desirable, including, without limitation, the granting of stock awards
and bonuses otherwise than under this Plan, and such arrangements may be either generally applicable or applicable only in specific cases.

 

26.            INSIDER TRADING POLICY.  Each Participant who receives an Award will comply with any policy adopted by the Company
from time to time covering transactions in the Company’s securities by Employees, officers and/or Directors of the Company, as well
as with any applicable insider trading or market abuse laws to which the Participant may be subject.

 

27.            ALL AWARDS SUBJECT TO COMPANY CLAWBACK OR RECOUPMENT POLICY.   All Awards, subject to applicable law, shall be
subject to clawback or recoupment pursuant to any compensation clawback or recoupment policy adopted by the Board or required by law during
the term of Participant’s employment or other service with the Company that is applicable to Employees, Directors or other service
providers of the Company, and in addition to any other remedies available under such policy and applicable law, may require the cancellation
of outstanding Awards and the recoupment of any gains realized with respect to Awards.

 

28.            DEFINITIONS. 
As used in this Plan, and except as elsewhere defined herein, the following terms will have the following meanings:

 

28.1.             “Affiliate” means any person or entity that directly or indirectly through one or more intermediaries controls,
or is controlled by, or is under common control with, the Company, including any general partner, managing member, officer or director
of the Company, in each case as of the date on which, or at any time during the period for which, the determination of affiliation is
being made.  For purposes of this definition, the term “control” (including the correlative meanings of the terms “controlled
by” and “under common control with”), as used with respect to any person or entity, means the possession, directly or
indirectly, of the power to direct or cause the direction of the management policies of such person or entity, whether through the ownership
of voting securities or by contract or otherwise.

 

28.2.             “Award” means any award under the Plan, including any Option, Restricted Stock, Stock Bonus, Stock Appreciation
Right, Restricted Stock Unit or Performance Award.

 

28.3.           
“Award Agreement” means, with respect to each Award, the written or electronic agreement between the Company
and the Participant setting forth the terms and conditions of the Award, and country-specific appendix thereto for grants to non-U.S.
Participants, which will be in substantially a form (which need not be the same for each Participant) that the Committee (or in the case
of Award agreements that are not used for Insiders, the Committee’s delegate(s)) has from time to time approved, and will comply
with and be subject to the terms and conditions of this Plan.

 

28.4.           
“Board” means the Board of Directors of the Company.

 

28.5.           
“Cause” means a determination by the Company (and in the case of Participant who is subject to Section 16
of the Exchange Act, the Committee) that the Participant has committed an act or acts constituting any of the following: (a) dishonesty,
fraud, misconduct or negligence in connection with Participant’s duties to the Company, (b) unauthorized disclosure or use
of the Company’s confidential or proprietary information or trade secrets, (c) misappropriation of a business opportunity of
the Company, (d) materially aiding Company competitor, (e) a conviction or plea of nolo contendere to a felony or crime involving
moral turpitude, (f) failure or refusal to attend to the duties or obligations of the Participant’s position (g) violation
or breach of, or failure to comply with, the Company’s code of ethics or conduct, any of the Company’s rules, policies or
procedures applicable to the Participant or any agreement in effect between the Company and the Participant or (h) other conduct
by such Participant that could be expected to be harmful to the business, interests or reputation of the Company.  The determination
as to whether Cause for a Participant’s termination exists will be made in good faith by the Company and will be final and binding
on the Participant.  This definition does not in any way limit the Company’s or any Parent’s or Subsidiary’s ability
to terminate a Participant’s employment or services at any time as provided in Section 20 above.  Notwithstanding the
foregoing, the foregoing definition of “Cause” may, in part or in whole, be modified or replaced in each individual employment
agreement, Award Agreement, or other applicable agreement with any Participant provided that such document specifically supersedes this
definition.

 

28.6.           
“Code” means the United States Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.

 

28.7.            “Committee” means the Compensation Committee of the Board or those persons to whom administration of the Plan,
or part of the Plan, has been delegated as permitted by law.

 

28.8.            “Company” means Beam Global., a Nevada corporation, or any successor corporation.

 

28.9.           
“Consultant” means any natural person, including an advisor or independent contractor, engaged by the Company
or a Parent, Subsidiary or Affiliate to render services to such entity.

  

 

 

    	 	12	 

     

    

 

28.10.         
“Corporate Transaction” means the occurrence of any of the following events: (a) any “Person”
(as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the “beneficial owner” (as defined
in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing more than fifty percent (50%)
of the total voting power represented by the Company’s then-outstanding voting securities; provided, however, that for purposes
of this subclause (a) the acquisition of additional securities by any one Person who is considered to own more than fifty percent
(50%) of the total voting power of the securities of the Company will not be considered a Corporate Transaction; (b) the consummation
of the sale or disposition by the Company of all or substantially all of the Company’s assets; (c) the consummation of a merger
or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities
of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into
voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the
voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation; (d) any
other transaction which qualifies as a “corporate transaction” under Section 424(a) of the Code wherein the stockholders
of the Company give up all of their equity interest in the Company (except for the acquisition, sale or transfer of all or substantially
all of the outstanding shares of the Company) or (e) a change in the effective control of the Company that occurs on the date that
a majority of members of the Board is replaced during any twelve (12) month period by members of the Board whose appointment or election
is not endorsed by a majority of the members of the Board prior to the date of the appointment or election.  For purpose of this
subclause (e), if any Person is considered to be in effective control of the Company, the acquisition of additional control of the Company
by the same Person will not be considered a Corporate Transaction.  For purposes of this definition, Persons will be considered to
be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or
similar business transaction with the Company.  Notwithstanding the foregoing, to the extent that any amount constituting deferred
compensation (as defined in Section 409A of the Code) would become payable under this Plan by reason of a Corporate Transaction,
such amount will become payable only if the event constituting a Corporate Transaction would also qualify as a change in ownership or
effective control of the Company or a change in the ownership of a substantial portion of the assets of the Company, each as defined within
the meaning of Code Section 409A, as it has been and may be amended from time to time, and any proposed or final Treasury Regulations
and IRS guidance that has been promulgated or may be promulgated thereunder from time to time.

 

28.11.         
“Director” means a member of the Board.

 

28.12.         
“Disability” means in the case of incentive stock options, total and permanent disability as defined in Section 22(e)(3) of
the Code and in the case of other Awards, that the Participant is unable to engage in any substantial gainful activity by reason of any
medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous
period of not less than 12 months.

 

28.13.         
“Dividend Equivalent Right” means the right of a Participant, granted at the discretion of the Committee or
as otherwise provided by the Plan, to receive a credit for the account of such Participant in an amount equal to the cash, stock or other
property dividends in amounts equivalent to cash, stock or other property dividends for each Share represented by an Award held by such
Participant.

 

28.14.         
“Effective Date” means ____________ 2021.

 

28.15.          
“Employee” means any person, including officers and Directors, providing services as an employee to the Company
or any Parent, Subsidiary or Affiliate.  Neither service as a Director nor payment of a director’s fee by the Company will
be sufficient to constitute “employment” by the Company.

 

28.16.         
“Exchange Act” means the United States Securities Exchange Act of 1934, as amended.

 

28.17          
“Exchange Program” means a program pursuant to which (a) outstanding Awards are surrendered, cancelled
or exchanged for cash, the same type of Award or a different Award (or combination thereof) or (b) the exercise price of an outstanding
Award is increased or reduced, each as described in Section 18.

 

28.18.         
“Exercise Price” means, with respect to an Option, the price at which a holder may purchase the Shares issuable
upon exercise of an Option and with respect to a SAR, the price at which the SAR is granted to the holder thereof.

 

 

 

    	 	13	 

     

    

 

28.19.        
“Fair Market Value” means, as of any date, the value of a share of the Company’s common stock determined
as follows:

 

(a)                    
if such common stock is publicly traded and is then listed on a national securities exchange, its closing price on the date of determination
on the principal national securities exchange on which the common stock is listed or admitted to trading as reported in The Wall Street
Journal or such other source as the Committee deems reliable;

 

(b)                    
if such common stock is publicly traded but is neither listed nor admitted to trading on a national securities exchange, the average of
the closing bid and asked prices on the date of determination as reported in The Wall Street Journal or such other source as the
Committee deems reliable; or

 

(c)                    
by the Board or the Committee in good faith.

 

28.20.         
“Insider” means an officer or Director of the Company or any other person whose transactions in the Company’s
common stock are subject to Section 16 of the Exchange Act.

  

28.21.          “IRS” means the United States Internal Revenue Service.

 

28.22.         
“Non-Employee Director” means a Director who is not an Employee of the Company or any Parent or Subsidiary.

 

28.23.          “Option” means an Award as defined in Section 5 and granted under the Plan.

 

28.24.         
“Parent” means any corporation (other than the Company) in an unbroken chain of corporations ending with the
Company if each of such corporations other than the Company owns stock possessing fifty percent (50%) or more of the total combined voting
power of all classes of stock in one of the other corporations in such chain.

 

28.25.         
“Participant” means a person who holds an Award under this Plan.

 

28.26.          “Performance Award” means an Award as defined in Section 10 and granted under the Plan.

 

28.27.         
“Performance Factors” means any of the factors selected by the Committee and specified in an Award Agreement,
from among the following objective or subjective measures, either individually, alternatively or in any combination applied to the Participant,
the Company, any business unit or Subsidiary, either individually, alternatively, or in any combination, on a GAAP or non-GAAP basis,
and measured, to the extent applicable on an absolute basis or relative to a pre-established target, to determine whether the performance
goals established by the Committee with respect to applicable Awards have been satisfied:

 

(a)                   
Profit Before Tax;

 

(b)                   
Sales;

 

(c)                   
Expenses;

 

(d)                   
Billings;

 

(e)                    
Revenue;

 

(f)                     
Net revenue;

 

(g)                    
Earnings (which may include earnings before interest and taxes, earnings before taxes, net earnings, stock-based compensation expenses,
depreciation and amortization);

 

 

 

    	 	14	 

     

    

 

(h)                   
Operating income;

 

(i)                     Operating margin;

 

(j)                     Operating profit;

 

(k)                    Controllable operating profit, or net operating profit;

 

(l)                     Net Profit;

 

(m)                   Gross margin;

 

(n)                    Operating expenses or operating expenses as a percentage of revenue;

 

(o)                    Net income;

 

(p)                    Earnings per share;

 

(q)                    Total stockholder return;

 

(r)                     Market share;

 

(s)                    Return on assets or net assets;

 

(t)                    The Company’s stock price;

 

(u)                   Growth in stockholder value relative to a pre-determined index;

 

(v)                    Return on equity;

 

(w)                   Return on invested capital;

 

(x)                    Cash Flow (including free cash flow or operating cash flows);

 

(y)                    Balance of cash, cash equivalents and marketable securities;

 

(z)                     Cash conversion cycle;

 

(aa)                   Economic value added;

 

(bb)                   Individual confidential business objectives;

 

(cc)                   Contract awards or backlog;

 

(dd)                 
Overhead or other expense reduction;

 

 

 

    	 	15	 

     

    

 

(ee)                   Credit rating;

 

(ff)                    Completion of an identified special project;

 

(gg)                  Completion of a joint venture or other corporate transaction;

 

(hh)                   Strategic plan development and implementation;

 

(ii)                      Succession plan development and implementation;

 

(jj)                      Improvement in workforce diversity;

 

(kk)                    Employee satisfaction;

 

(ll)                      Employee retention;

 

(mm)                
Customer indicators and/or satisfaction;

 

(nn)                  
New product invention or innovation;

 

(oo)                  
Research and development expenses;

 

(pp)                  
Attainment of research and development milestones;

 

(qq)                  
Improvements in productivity;

 

(rr)                    
Bookings;

 

(ss)                   
Working-capital targets and changes in working capital;

 

(tt)                    
Attainment of operating goals and employee metrics; and

 

(uu)                  
Any other metric as determined by the Committee.

 

The Committee may provide for one or more equitable
adjustments to the Performance Factors to preserve the Committee’s original intent regarding the Performance Factors at the time
of the initial award grant, such as but not limited to, adjustments in recognition of unusual or non-recurring items such as acquisition
related activities or changes in applicable accounting rules.  It is within the sole discretion of the Committee to make or not make
any such equitable adjustments.

 

28.28.          “Performance Period” means one or more periods of time, which may be of varying and overlapping durations, as
the Committee may select, over which the attainment of one or more Performance Factors will be measured for the purpose of determining
a Participant’s right to, and the payment of, a Performance Award.

 

28.29.          “Performance Share” means an Award as defined in Section 10 and granted under the Plan.

 

 

    	 	16	 

     

    

 

28.30.          “Permitted Transferee” means any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former
spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law (including
adoptive relationships) of the Employee, any person sharing the Employee’s household (other than a tenant or employee), a trust
in which these persons (or the Employee) have more than 50% of the beneficial interest, a foundation in which these persons (or the Employee)
control the management of assets, and any other entity in which these persons (or the Employee) own more than 50% of the voting interests.

 

28.31.         
“Performance Unit” means an Award as defined in Section 10 and granted under the Plan.

 

28.32.         
“Plan” means this Beam Global 2021 Equity Incentive Plan.

 

28.33.         
“Purchase Price” means the price to be paid for Shares acquired under the Plan, other than Shares acquired upon
exercise of an Option or SAR.

 

28.34.         
“Restricted Stock Award” means an Award as defined in Section 6 and granted under the Plan (or
issued pursuant to the early exercise of an Option).

 

28.35.         
“Restricted Stock Unit” means an Award as defined in Section 9 and granted under the Plan.

 

28.36.         
“SEC” means the United States Securities and Exchange Commission.

 

28.37.         
“Securities Act” means the United States Securities Act of 1933, as amended.

 

28.38.         
“Service” means service as an Employee, Consultant, Director or Non-Employee Director, to the Company or a Parent,
Subsidiary or Affiliate, subject to such further limitations as may be set forth in the Plan or the applicable Award Agreement. 
An Employee will not be deemed to have ceased to provide Service in the case of (a) sick leave, (b) military leave, or (c) any
other leave of absence approved by the Company; provided, that such leave is for a period of not more than 90 days unless reemployment
upon the expiration of such leave is guaranteed by contract or statute.  Notwithstanding anything to the contrary, an Employee will
not be deemed to have ceased to provide Service if a formal policy adopted from time to time by the Company and issued and promulgated
to employees in writing provides otherwise.  In the case of any Employee on an approved leave of absence or a reduction in hours
worked (for illustrative purposes only, a change in schedule from that of full-time to part-time), the Committee may make such provisions
respecting suspension or modification of vesting of the Award while on leave from the employ of the Company or a Parent, Subsidiary or
Affiliate or during such change in working hours as it may deem appropriate, except that in no event may an Award be exercised after the
expiration of the term set forth in the applicable Award Agreement.  In the event of military or other protected leave, if required
by applicable laws, vesting will continue for the longest period that vesting continues under any other statutory or Company approved
leave of absence and, upon a Participant’s returning from military leave, he or she will be given vesting credit with respect to
Awards to the same extent as would have applied had the Participant continued to provide Service to the Company throughout the leave on
the same terms as he or she was providing Service immediately prior to such leave.  An Employee will have terminated employment as
of the date he or she ceases to provide Service (regardless of whether the termination is in breach of local employment laws or is later
found to be invalid) and employment will not be extended by any notice period or garden leave mandated by local law, provided however,
a change in status from an Employee to a Consultant or a Non-Employee Director (or vice versa) will not terminate a Participant’s
Service, unless determined by the Committee, in its discretion or to the extent set forth in the applicable Award Agreement.  The
Committee will have sole discretion to determine whether a Participant has ceased to provide Service and the effective date on which the
Participant ceased to provide Service.

 

28.39.         
“Shares” means shares of the common stock of the Company.

 

28.40.         
“Stock Appreciation Right” means an Award as defined in Section 8 and granted under the Plan.

 

 

 

    	 	17	 

     

    

 

28.41.         
“Stock Bonus” means an Award granted pursuant to Section 7 of the Plan.

 

28.42.         
“Subsidiary” means any corporation (other than the Company) in an unbroken chain of corporations beginning with
the Company if each of the corporations other than the last corporation in the unbroken chain owns stock possessing fifty percent (50%)
or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.

 

28.43.         
“Treasury Regulations” means regulations promulgated by the United States Treasury Department.

 

28.44.         
“Unvested Shares” means Shares that have not yet vested or are subject to a right of repurchase in favor of
the Company (or any successor thereto).

 

 

 

 

 

 

 

 

 

    	 	18

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]